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Multiple neurodegenerative diseases are caused by the aggre-
gation of the human -Synuclein (-Syn) protein. -Syn pos-
sesses high structural plasticity and the capability of interacting
with membranes. Both features are not only essential for its
physiological function but also play a role in the aggregation
process. Recently it has been proposed that-Syn is able to form
lipid-protein particles reminiscent of high-density lipoproteins.
Here, we present a method to obtain a stable and homogeneous
population of nanometer-sized particles composed of -Syn
and anionic phospholipids. These particles are called -Syn
lipoprotein (nano)particles to indicate their relationship to
high-density lipoproteins formed by human apolipoproteins in
vivo and of in vitro self-assembling phospholipid bilayer nano-
discs. Structural investigations of the -Syn lipoprotein parti-
cles by circular dichroism (CD) and magic angle solid-state
nuclear magnetic resonance (MAS SS-NMR) spectroscopy
establish that -Syn adopts a helical secondary structure within
these particles. Based on cryo-electron microscopy (cryo-EM)
and dynamic light scattering (DLS) -Syn lipoprotein particles
have a defined size with a diameter of23 nm. Chemical cross-
linking in combinationwith solution-stateNMRandmultiangle
static light scattering (MALS) of -Syn particles reveal a high-
order protein-lipid entity composedof8–10-Synmolecules.
The close resemblance in size between cross-linked in vitro-de-
rived -Syn lipoprotein particles and a cross-linked species of
endogenous -Syn from SH-SY5Y human neuroblastoma cells
indicates a potential functional relevance of -Syn lipoprotein
nanoparticles.
Synucleinopathies are neurodegenerative diseases; the three
major ones being Parkinson’s disease, dementiawith Lewy bod-
ies, and multiple system atrophy; caused by the accumulation
and aggregation of the -Synuclein (-Syn)2 protein (1, 2).
Human -Syn is an abundant brain protein possessing consid-
erable structural plasticity. In aqueous solution, monomeric
-Syn is largely disordered (3–5) while in amembranemimick-
ing environment (5, 6) monomeric -Syn undergoes a struc-
tural transition toward a helical state. During pathological
aggregation -Syn forms oligomeric species and ultimately
mature amyloid fibrils, the latter consisting mainly of -sheet
structure (7–9). Binding of -Syn tomembranes is mediated by
seven imperfect repeats in the N-terminal region of its primary
sequence, which are reminiscent of those found in the
amphipathic helices of apolipoproteins (3, 6, 10, 11). The inter-
action with biological membranes is at the basis of the multiple
in vivo functions attributed to-Syn so far: synaptic vesicle pool
maintenance (12, 13), regulation of dopamine neurotransmis-
sion (14, 15), transport of lipids and fatty acids (16–20), mem-
brane trafficking (21–23), synaptic plasticity (10, 24, 25), and
assistance in SNARE complex formation (26–29). Finally,
membranes play a role in -Syn aggregation too, although their
precise effect is still unclear as both inhibition and promotion
have been reported (30–34).
-Syn preferentially binds to membranes containing anionic
phospholipids (6, 35) and to anionic detergents such as sodium
dodecyl sulfate (SDS) (3). Upon binding, the N-terminal region
of -Syn undergoes a structural transition toward a helical
state, while the C-terminal one remains substantially unstruc-
tured. Initial studies by solution-state nuclear magnetic reso-
nance (NMR) and electron paramagnetic resonance (EPR)
spectroscopy performed in the presence of SDS or anionic
small unilamellar vesicles (SUVs), respectively, suggested that
the first100 residues of-Syn form a single extended helix (5,
36). Subsequent NMR data collected of -Syn in complex with
SDSproposed an alternative state, often termedhorseshoe con-
formation, consisting of two distinct helices interrupted by a
short break (11, 37–40).While some studies suggested that the
horseshoe conformation results from the constraints imposed
by the reduced size and higher curvature of detergent micelles
(36, 41, 42), others reported evidence of helix breaking even
with SUVs large enough to accommodate the extended helix
(43, 44). Nowadays, it is accepted that multiple binding modes
of -Syn to lipids exist (45, 46) and that the horseshoe and
* This work was supported by a Swiss National Foundation Sinergia grant.
The authors declare that they have no conflicts of interest with the con-
tents of this article.
1 To whom correspondence should be addressed. E-mail: roland.riek@
phys.chem.ethz.ch.
2 The abbreviations used are: -Syn, -Synuclein; SUV, small unilamellar ves-
icle; MSP, membrane scaffolding protein; CD, circular dichroism; SEC, size
exclusion chromatography; MAS SS-NMR, magic angle solid-state NMR;
MALS, multiangle static light scattering; DLS, dynamic light scattering;
DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine; POPS, 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospho-L-serine; DSG, disuccinimidyl glutarate; DABMI,
4-dimethylaminophenylazophenyl-4maleimide.
crossmark
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 291, NO. 16, pp. 8516–8527, April 15, 2016
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
8516 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 16•APRIL 15, 2016
 at U
niversitaetsbibliothek M
edizin on January 25, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
extended helical states can coexist and even undergo inter-con-
version (47–50). Not only does the interaction of -Syn with
lipid membranes induce changes in the protein conformation,
but also cause a remodeling of the membranes due to mem-
brane thinning (51–53) and membrane curvature changes (51,
54–57).
Interestingly, at high protein-to-lipid ratios, -Syn was
reported to be able to reshape giant lipid vesicles into lipopro-
tein nanoparticles (58) (7–10 nm size) having a morphology
and shape similar to that of high-density lipoproteins and self-
assembling phospholipid bilayer nanodiscs (59) formed by
human apolipoproteins and membrane scaffolding proteins
(MSPs). In these complexes, -Syn appears to be multimeric
and adopts a broken helical conformation. However, an exact
determination of the molecular weight of the multimer and
more generally of the properties of these particles is hampered
by the heterogeneity of the sample preparations (58). In this
work, stable and homogeneous populations of nanoparticles
composed of phosphatidylserine lipids and -Syn were
obtained with the protocol typically used to prepare in vitro
synthetic nanodiscs (60, 61). Thismethod ensured a high extent
of sample homogeneity, which in turn allowed a detailed bio-
physical characterization of the particles.
Experimental Procedures
Expression and Purification of -Synuclein—Recombinant
wild-type (WT) human -Syn and the -Syn variant
-Syn(C141) were overexpressed in the Escherichia coli strain
BL21 StarTM (DE3) pLysS (Invitrogen) and purified as
described previously (62). 2H, 15N-, and 13C,15N-labeled human
-Synwere produced using standardM9minimalmedium (63)
based on D2O (Isotec) and H2O, respectively, supplemented
with 3 g/liter 13C glucose (Isotec), and 1 g/liter 15NH4Cl
(Isotec).
Preparation of -Synuclein Lipoprotein Particles—Lipopro-
tein particles consisting of -Syn and different types of lipids
were produced using 1,2-dioleoyl-sn-glycero-3-phospho-L-ser-
ine (DOPS), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-ser-
ine (POPS), and sphingomyelin (brain, porcine) synthetic lipids
(Avanti Polar Lipids). The lipids were solubilized in sodium
cholate with a 2-fold molar excess of detergent and stored in a
glass vial. -Syn-derived lipoprotein particles were assembled
following established protocols for the preparation of MSP
nanodiscs (61). In details, -Syn in 10 mM Na2HPO4 pH 7.0
buffer was mixed with the lipids dissolved in sodium cholate
and the obtained samplewas incubated overnight at 27 °Cwhile
shaking at 150 rpm. Different protein-to-lipid ratios were used
as described under “Results” (see below). The formation of
-Syn nanodiscs was initiated with the addition of 80% w/v
Biobeads SM2 (Bio-Rad) for 2 more hours at 27 °C while shak-
ing at 150 rpm. The obtained preparations were injected into a
Superdex 200 10/300GL size-exclusion chromatography (SEC)
column (GEHealthcare) and eluted at a flow rate of 0.5 ml/min
in (i) 20 mM Bis-Tris-HCl pH 7.0, 150 mM NaCl for transmis-
sion electron microscopy, (ii) 1 phosphate-buffered saline
(PBS) pH 7.0 for multiangle static light scattering (MALS), and
(iii) 20 mM HEPES pH 7.5, 150 mM NaCl for in vitro cross-
linking experiments, respectively. The different buffers did not
affect the position and the width of the -Syn lipoprotein par-
ticle peak in the SEC elution profile (data not shown). The pro-
tein peak corresponding to the species of interest were merged
and either buffer-exchanged for solution- and solid-state NMR
in 20 mM Bis-Tris-HCl, pH 7.0, 20 mM NaCl using a PD10
desalting column (GE Healthcare), or used directly for subse-
quent analysis. When required, the concentration of the eluted
samplewas increased by using a 3-kDamolecularweight cut-off
Centricon (Amicon) concentrator.
Circular Dichroism (CD)—CD spectra of monomeric -Syn
and -Syn DOPS lipoprotein particles were collected using a
Jasco J-815 CD spectrometer with a 1-mm quartz cell at 25 °C.
Spectra were averaged from 10 replicates acquired at 0.2 nm
step resolution from 195–260 nm with a spectral bandwidth of
1 nm, a scanning speed of 20 nm/min, and a data integration
time of 2 s. The spectra of 9.0 M monomeric -Syn and 11.5
M -Syn DOPS lipoprotein particles were recorded in 9.9 mM
and 8.6 mM Na2HPO4, pH 7, respectively, containing 0.1x PBS
pH 7. Appropriate blanks under the same conditions were sub-
tracted resulting in the final spectra.
Dynamic Light Scattering (DLS)—DLS measurements of
-Syn DOPS lipoprotein particles were performed directly
after SEC on a Zetasizer Nano ZS (Malvern Instruments)
Dynamic Light Scattering instrument equipped with a Peltier
temperature controller set at room temperature. Disposable
micro-cuvettes for size measurements at a scattering angle of
173° were used. Every samplewasmeasured three times and the
averaged intensity-size distribution is reported.
Negative-Stain Electron Microscopy (EM)—-Syn lipopro-
tein particles were diluted to 10 M in 20 mM Bis-Tris-HCl,
pH7.0, 150mMNaCl. An aliquot of 5l was deposited for 1min
on a glow-discharged carbon-coated copper grid for EM. The
grids were blotted and washed twice with drops of water before
staining with 2% w/v uranyl acetate for 15 s. EM images were
acquired using a FEI Morgagni 268 transmission electron
microscope operated at 100 kV.
Cryo-Electron Microscopy (cryo-EM)—-Syn lipoprotein
particles were diluted to a concentration of13.8M in 20mM
Bis-Tris-HCl pH 7.0, 150 mM NaCl. Aliquots of 3 l were
applied to glow-discharged holey-carbon film coated copper
grids (Quantifoil GmbH, Jena, Germany), blotted, and vitrified
in a FEI Vitrobot Mark IV freezing device. Grids were trans-
ferred to a Philips CM200FEG cryo-EM instrument, operated
at 200 kV, and images were recorded on a TVIPS F416 CMOS
camera, using an electron dose of 20 electrons/Å2 and a nomi-
nal magnification of 50 kx.
Image Processing—For images of negatively stained -Syn
lipoprotein particles, 7650 particles were manually selected
using Boxer from the EMAN2 suit (64), aligned, and classified
using EMAN2.
For cryo-EM images of-Syn lipoprotein particles, 9300 par-
ticles were manually selected from 108 images using Boxer.
Particle images were aligned and classified into 100 2D classes
using EMAN2.
Solution-State NMR Spectroscopy—All solution-state NMR
spectra were recorded at 30 °C on a Bruker 700MHzAvance III
spectrometer equipped with a triple resonance cryoprobe.
Two-dimensional [15N,1H]-TROSY (65) spectra (time domain
-Synuclein-derived Lipoprotein Particles
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data size 256*2048 complex points, t1max(15N)  44.8 ms and
t2max(1H)  204.9 ms) were collected from samples consisting
of different unlabeled lipids and 2H, 15N-labeled -Syn pre-
pared with the procedure described above. The lipid-free
state of -Syn was measured using a 1.5-mM sample of 13C,
15N-labeled -Syn. three-dimensional constant time (ct)-
TROSY-HNCA, three-dimensional ct-TROSY-HNCACB (66),
and three-dimensional ct-TROSY-HN(CO)CA (67) experi-
ments were acquired for sequential assignment (68) of 1H, 13C,
and 15Nbackbone resonances. The spectrawere processedwith
the program PROSA (69) and analyzed with the program
XEASY (70). 15N-edited diffusion measurements with increas-
ing diffusion coding gradient strengths (4 ms total duration)
and a 105-ms diffusion delay were recorded for a total of 2048
transients per gradient strength.
Solid-State NMR Spectroscopy—A sample of uniformly 13C,
15N-labeledWT human -Syn DOPS lipoprotein particles was
filled into a ZrO2 3.2-mm rotor (Bruker) using a home-made
filling tool (71) in a SW40 TI rotor and an optima L90-K ultra-
centrifuge (Beckman). Solid-state NMR experiments were per-
formed at 15 °C on a Bruker 850 MHz Avance II spectrometer
using a Bruker triple-resonance 3.2 mm Efree probe. A 20-ms
DARR spectrum was recorded (time domain data size
1024*3072 complex points, t1max(13C)  10.2 ms and
t2max(13C) 15.4ms) and processed using topspin 2.1 (Bruker).
In Vitro Cross-Linking—Purified -Syn DOPS lipoprotein
particles in 20 mM HEPES pH 7.5, 150 mM NaCl were cross-
linked using disuccinimidyl glutarate (DSG) purchased from
Thermo Scientific. Immediately before usage, DSG was dis-
solved at 25 mM in DMSO. At a final concentration of 83 M
-Syn DOPS lipoprotein particles and 0.249–4.2 mM DSG
cross-linker, the samples were incubated for 30 min at 37 °C
while shaking at 600 rpm. The cross-linking reaction was
quenched by adding 1 M Tris-HCl, pH 7.5 to a final concentra-
tion of 50 mM and mixing the samples for additional 15 min at
25 °C at 600 rpm.
In Vivo Cross-Linking—SH-SY5Y human neuroblastoma
cells expressing endogenous -Syn were purchased from
ATCC and cultured in DMEM medium supplemented with
10% fetal calf serumand 1%penicillin-streptomycin-glutamine.
Five 10-cm dishes were grown at 80% confluence, then har-
vested in PBS supplemented with protease inhibitor mixture
(Roche) (72) and washed twice with the same buffer. Samples
containing8.106 cells in 200l PBS buffer supplementedwith
protease inhibitor mixture were cross-linked with 2 mM DSG
(final concentration) using the in vitro cross-linking protocol
(see above). After quenching the reaction, the cells were lysed
by 15-s sonication using a microtip at 39% power followed by
centrifugation at 25,000 g. The supernatant was used for the
subsequent immunoblotting (see below).
Gel Electrophoresis and Immunoblotting—The samples
obtained from the cross-linking experiments were mixed with
Laemmli buffer at ratio 1:1 and subsequently analyzed by SDS-
PAGE. For the analysis of in vitro cross-linking reactions,
4–12% gradient NuPAGE Bis-Tris gels (Invitrogen) were used
and stained with Coomassie Brilliant Blue. Immunoblotting
was carried out for detection of in vitro and in vivo cross-linked
samples using a 15% polyacrylamide gel. Nitrocellulose mem-
branes were incubated in PBS containing 0.4% paraformalde-
hyde for 30 min at room temperature (72), rinsed twice with
FIGURE 1. -Syn-containing lipoprotein particles are well defined in size. A, size-exclusion gel chromatography (Superdex 200 10/300GL) of -Syn DOPS
(black), -Syn POPS (green), and -Syn sphingomyelin (red) lipoprotein particles. Monomeric (gray) -Syn elutes at 14.3 ml. B, dynamic light scattering of
-Syn-containing DOPS lipoprotein particles. The size-exclusion chromatography fraction at the maximum of the absorbance of 280 nm (9.5–10 ml) consists
of particles with an average hydrodynamic radius of 25.8 0.8 nm. C–E, negatively stained electronmicrographs containing themaxima of the size-exclusion
chromatography fractions at the absorbance of 280 nm of purified (C) -Syn DOPS, (D) -Syn POPS, and (E) -Syn sphingomyelin lipoprotein particles. The
radius varies from19–28 nm, scale bar 100 nm.
-Synuclein-derived Lipoprotein Particles
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PBS, and blocked in PBS-T buffer (PBS containing 0.05%
Tween-20 (Sigma)) supplemented with 5% fat-free milk for 1 h
at room temperature. After blocking, membranes were incu-
bated with the primary anti--Synuclein antibody LB509 (at
1:5000 dilution, from Abcam) for 1 h at room temperature fol-
lowed by three washes for 10 min with PBS-T. Subsequently,
the washedmembranes were incubated in blocking buffer con-
taining the goat anti-mouse antibody conjugated to horseradish
peroxidase (at 1:3000 dilution from Bio-Rad) for 1 h at room
temperature. The membranes were then washed three times
for 10 min in PBS-T and developed with enhanced chemilumi-
nescence (ECL Prime, GE Healthcare) according to the man-
ufacturer’s instructions.
Multiangle Static Light Scattering (MALS)—The oligomeric
state of-Syn inDOPS lipoprotein particles was determined by
multiangle static light scattering coupled with SEC and refrac-
tive index measurements. An additional C-terminal cysteine at
position 141, denoted -Syn(C141), was introduced in human
-Syn and labeled with 4-dimethylaminophenylazophenyl-
4maleimide (DABMI) (Invitrogen) according to manufactu-
rer’s instructions. The average molar weights of the protein-
lipid complex, the protein, and the lipid fraction in the -Syn
DOPS lipoprotein particles were then determined at the absor-
bance of DABMI (454 nm) using a protein extinction coeffi-
cient of 1666ml/(g cm), protein dn/dc 0.185ml/g, andDOPS
dn/dc 0.141 ml/g, respectively.
Results
Preparation, Morphology, and Size of -Synuclein-derived
Lipoprotein Particles—Nanometer-sized particles consisting of
lipids and -Syn, hereafter called -Syn lipoprotein particles,
were produced following protocols previously used to obtain in
vitro nanodiscs from lipids and MSPs (60, 61). Briefly, the pro-
tein was first mixed with the desired lipids dissolved in sodium
cholate. After incubation, the detergent was removed, and the
phospholipid bilayer was encapsulated by -Syn molecules. To
separate lipid-bound -Syn from residual monomeric protein,
the sample was subjected to size exclusion chromatography
(SEC). Several ratios of -Syn to the lipids of interest were
tested. The formation of -Syn lipoprotein particles and
the extent of incorporation of -Syn into these complexes were
then monitored by SEC (Fig. 1A). The elution profiles in the
presence of DOPS or POPS phospholipids showed that at a
molar protein-to-lipid ratio of 1 to 40 full incorporation of
-Syn and lipids into -Syn lipoprotein particles were obtained
(Fig. 1A, please note that -Syn monomer elutes at 14.7 ml).
Additionally, sphingomyelin was used to assess whether the
binding of -Syn to a natural, zwitterionic lipid can also result
FIGURE 2. Electronmicroscopy of-SynDOPS lipoprotein particles. A, electronmicrograph of negatively stained-Syn lipoprotein particles. Both top and
side views of the nanoparticles are visible (scale bar 100 nm). B, two-dimensional classification of -Syn lipoprotein particles (scale bar 10 nm).
-Synuclein-derived Lipoprotein Particles
APRIL 15, 2016•VOLUME 291•NUMBER 16 JOURNAL OF BIOLOGICAL CHEMISTRY 8519
 at U
niversitaetsbibliothek M
edizin on January 25, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
in the formation of -Syn lipoprotein particles. Sphingomyelin
is a component of synaptic vesicles and is the most abundant
sphingolipid in human cell membranes. Interestingly, when
-Syn was incubated with sphingomyelin at the same protein-
to-lipid ratio as used for the negatively charged lipids, a residual
amount of monomeric -Syn (peak at 14.7 ml) was detected in
the SEC indicating that the formation of -Syn lipoprotein par-
ticles is more comprehensive with negatively charged lipids
(Fig. 1A).
Subsequently, the morphology of the -Syn lipoprotein par-
ticles prepared with either of the lipids (i.e. DOPS, POPS, and
sphingomyelin) eluting at9.8 ml in the SEC were assessed by
negative-stain EM (Fig. 1, C–E, Fig. 2). From EM images of
negatively stained particles, 7650 particles were manually
selected, aligned, and classified. A population of circular parti-
cles having a diameter of19–28nmwas observed. In linewith
this finding are the results from DLS measurements on -Syn
DOPS lipoprotein particles, where the most abundant particles
present in the sample appeared to have a Z-average size of
25.8 0.8 nm (from cumulate analysis of three repeated mea-
surements of the same sample) and a poly-dispersion index of
0.20 0.02 (Fig. 1B). Next, the -Syn DOPS lipoprotein parti-
cles were examined in detail by cryo-EM (Fig. 3). A total of 9300
-SynDOPSparticleswere selected fromelectronmicrographs
and subjected to classification and class-averaging procedures.
The characteristic class averages (Fig. 3C) showed roundish/
ellipsoidal particles with a low-density inner region attributed
to the DOPS bilayer of 10 nm in diameter, which is sur-
rounded by a6–7 nm wide -Syn belt of higher density (Fig.
3, D and E). Similar to the architecture of lipoprotein particles
formed by the apolipoprotein A1 (73, 74) and -Syn induced
nanoparticles (58), the observed higher density features at the
periphery of the discs are compatible with the interpretation
that -Syn molecules are wrapped around the DOPS lipids in a
ring-like manner (Fig. 3E).
The collected data indicate that our protocol allows obtain-
ing nanometer-sized particles composed of -Syn and anionic
phospholipids, and that such samples have a uniform size as
determined by the relatively small width of both the SEC elu-
tion profile peak and the DLS size distribution poly-dispersion
index (Fig. 1,A andB). The samples eluted from the SEC appear
to be quite stable, since increasing their concentration and re-
injecting them in the same SEC column did not change the
elution profile (data not shown). Storage at 4 °C over a couple of
weeks did not alter the morphology as evidenced by EM (data
not shown).
Helical Secondary Structure of-Synuclein in the Lipoprotein
Particles—Circular dichroism (CD) was used to compare the
secondary structure of monomeric -Syn versus that of the lip-
id-bound state prepared as described above (Fig. 4A). In line
FIGURE 3. Cryo-electron microscopy images of -Syn DOPS lipoprotein particles. A, on the cryo-electron micrograph mostly side views of -Syn DOPS
lipoprotein particles are well visible. B, -Syn DOPS lipoprotein particles have a tendency to aggregate. C, two-dimensional classification of -Syn DOPS
lipoproteinparticles. Threemainpopulationsof nanoparticleswithdiameters of 19–21nm, 23–24nm, 27–28nm, respectively,wereobserved.D, sideand E, top
view of two-dimensional nanoparticle classes with a diameter of23 nm. The scale bars indicate 100 nm in (A, B) and 10 nm in (C–E).
-Synuclein-derived Lipoprotein Particles
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with previous studies by many authors, the measured CD spec-
trumofmonomeric-Syn had the features of highly disordered
proteins, with a maximum negative ellipticity per residue
([]MRW) at 199 nm (3–6). In contrast, the CD spectrum of
-Syn DOPS lipoprotein particles, which eluted in the SEC at
9.8 ml, had the characteristics of -helical proteins, with two
negative []MRW peaks at210 and 221 nm, respectively, and
one positive []MRW peak at 195 nm. This spectrum resem-
bles those obtained upon binding of -Syn to anionic lipid ves-
icles and anionic detergents (3, 5, 6).
In addition to CD, the-helical secondary structure of-Syn
in -Syn DOPS lipoprotein particles was verified by magic
angle solid-state NMR (MAS SS-NMR). Observed 13C-13C
cross-peaks for alanine and valine amino acid residues in the
13C-13C DARR correlation spectrum of 13C, 15N-labeled -Syn
DOPS lipoprotein particles fell within the regions typical
detected for -helices (75) (Fig. 4B). Thus, CD together with
chemical shift MAS SS-NMR analyses indicated that -Syn
DOPS lipoprotein particles contain -helical secondary struc-
ture elements.
Next, we collected two-dimensional [15N,1H]-TROSY solu-
tion-state NMR spectra of 2H, 15N-labeled -Syn DOPS lipo-
protein particles and free 13C, 15N-labeled -Syn (Fig. 5). As
expected for a largely disordered protein, the two-dimensional
[15N,1H]-TROSY spectrum of free -Syn has a resonance dis-
persion of 1 ppm in the proton dimension. Although often
overlapped, all expected peaks were found and assigned (Fig.
5A) in agreementwith others (5, 37). Comparedwith that of the
free protein, the spectra of -Syn DOPS, -Syn POPS, and
-Syn sphingomyelin lipoprotein particles showed instead
cross peaks of only the 40 C-terminal residues (Fig. 5, B–D).
Increasing the temperature by 20 °C or lowering the pH to 4.5
did not increase the number of cross peaks visible in the two-
dimensional [15N,1H]-TROSY spectra of -Syn lipoprotein
particles (data not shown). These studies indicate that the40
C-terminal residues are flexible and do not take part in the core
structure of the-Syn lipoprotein particle. Similar observations
have been documented also for -Syn studies in presence of
SDSmicelles or SUVs containing anionic phospholipids (5, 37).
In summary, taken the results from CD, MAS SS-NMR, and
solution-state NMR together, residues 1–100 of WT human
-Syn adopt an -helical structure while the 40 C-terminal
residues remain unstructured in -Syn lipoprotein particles.
The Protein-Lipid Composition of -Synuclein Lipoprotein
Particles—To address the composition of the membrane-
bound state of -Syn in DOPS lipoprotein particles, and in par-
ticular whether -Syn stays monomeric in the complex or
adopts a multimeric form, we performed chemical cross-link-
ing experiments with the disuccinimidyl glutarate (DSG, spacer
length 7.7 Å) linker. By doing so, we would like to note that
interpretations of chemical cross-linking experiments of pro-
tein complexes have to be taken with care because they may be
inherently inefficient and depend on the size of the cross-link-
ing molecule, which can also nonspecifically link proteins to
each other in a diffusion-controlled reaction at high cross-
linker concentrations (28, 76, 77) or the cross-linker may cova-
lently attach phospholipids to -Syn (28). We treated our sam-
ples with the DSG cross-linker, because its high efficiency was
reported in recent in vivo cross-linking experiments (72) of
-Syn. We observed well-resolved monomeric, dimeric, trim-
eric up to octa-decameric bands by SDS-PAGE (Fig. 6,A andB).
At higher DSG concentration, a predominant single150 kDa
specieswas detected (Fig. 6B). Intramolecular cross-linkingwas
investigated by varying the -Syn DOPS lipoprotein particle
concentration keeping thereby the used DSG amount constant
(Fig. 6C). We observed weaker bands on SDS-PAGE gels with
decreasing concentration of -Syn DOPS lipoprotein particles
(Fig. 6C) indicating that -Synmolecules were not cross-linked
between different lipoprotein particles. In the absence of DSG,
-Syn DOPS lipoprotein particles ran as a monomer on a SDS-
PAGE. Importantly, free -Syn remained monomeric in pres-
ence of different DSG cross-linker concentrations (Fig. 6D).
The amino acid sequence of-Syn contains fifteen Lys residues
that are targeted by the DSG cross-linker. An increasing con-
centration of DSG results in a larger number of DSG-modified
Lys residues and therefore in a larger molecular weight distri-
bution of unfolded monomeric DSG-bound -Syn that is man-
ifested by broader and weaker bands on a SDS-PAGE (Fig. 6D).
In contrast to the studies by Dettmer et al. (72), we find no
evidence that unfolded monomeric -Syn favors in vitro inter-
FIGURE 4.Helical secondary structure of-Syn in lipoprotein particles. A,
conformational change of -Syn determined by CD from a predominantly
unfolded state (black) free in solution to an -helical state in -Syn DOPS
lipoprotein particles (red). For the -Syn DOPS lipoprotein particles, the size
exclusion chromatography fraction 9.5–10 ml (Fig. 1A) was used. B, two-di-
mensional 13C DARR solid-state NMR spectra (at a magnetic field of 850 MHz
1H frequency) of uniformly 13C, 15N-labeled-SynDOPS lipoprotein particles.
The assigned cross peaks fromAla andVal residues are indicatedbygreen and
cyan boxes, respectively. Indicated with dotted green and cyan lines are the
randomcoil 13C, 13C chemical shifts for the amino acid residues Ala and Val,
respectively.Arrows show the chemical shift area typically observed for-hel-
ical secondary structure.
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actions with other -Syn molecules forming a stable tetramer
(78). These data indicate that-SynDOPS lipoprotein particles
are composed of 8–10 -Syn molecules.
Next, one-dimensional (1D) 15N-filtered solution-state
NMR diffusion experiments were used to assess the molecular
weight of the -Syn lipoprotein particles. The measured trans-
lational diffusion coefficient of 2.3.107 cm2 s1 is similar for
DOPS, POPS, and sphingomyelin -Syn lipoprotein particles.
From the diffusion coefficient a rough estimate for the apparent
molecular weight of the -Syn lipoprotein particles of 400
kDa is obtained.
An exact mass and composition of a protein-lipid entity can
however only be determined by size exclusion coupled multi-
angle static light scattering (MALS) combined with refraction
index measurements (79). In the case of -Syn lipoprotein par-
ticles a fluorophore-labeled -Syn(C141) variant, which was
labeled at the additionally introduced C-terminal residue Cys-
141 with the dye DABMI, was used for the protein detection in
the MALS studies because the large molecular weight of the
complex may cause potential scattering issues. By doing so we
observed a molecular weight of 982 kDa for the total -Syn
DOPS lipoprotein particle complex, 865 kDa for the DOPS
lipids, and116 kDa for the protein component (Fig. 7). These
measures indicate that -Syn DOPS lipoprotein particles are
composed of eight -Syn and 1070 DOPS molecules with a
protein-to-lipid mass ratio of 1:8 (Fig. 7). By comparison, a
maximum of 620 lipid molecules are observed in nanodiscs
assembled with DPPC and two apolipoprotein A-1 derived
MSP2N2 constructs (61). The -Syn-to-DOPS ratio is in line
with a subsequent comparison of the integrated -Syn 1HN sig-
nals (7.8 - 8.5 ppm) with the signal from the polar head methyl
group of DOPS at 3.2 ppm extracted from a one-dimensional
1H NMR spectrum of -Syn DOPS lipoprotein particles show-
ing a protein-to-lipid ratio in the range of 1:10 (data not
shown).
-SynucleinAdopts anOligomeric State inVivo Similar to the
Lipoprotein Particles—To investigate whether -Syn lipopro-
tein particles may exist in a natural cellular environment, we
used SH-SY5Y human neuroblastoma cells that express endog-
enous human -Syn. Native assemblies of -Syn were trapped
through the cell-permeable DSG cross-linker (72). In addition
to monomeric -Syn, predominant SDS-stable high molecular
weight -Syn species of 60 and 90 kDa were detected in the
supernatant of unpurified non-cross-linked SH-SY5Y cells (Fig.
8; left panel, first lane). The presence of SDS-stable highmolec-
ular weight -Syn species (72) have been described before sug-
gesting that they may be building blocks for larger -Syn olig-
omers, which cause toxicity by aggregation to the cell
membrane (80, 81). Upon addition of DSG cross-linker we
observed a trapped high molecular weight 150 kDa -Syn
species in neuroblastoma cells accompanied with a decrease of
themonomeric and 60–90 kDa -Syn species (Fig. 8; left panel,
second and third lane). The discrete pronounced 150-kDa
band indicates specific interactions between multiple -Syn
monomers since a completely diffusion-controlled (nonspe-
cific) cross linking would have resulted in diffuse continuous
bands from -Syn cross-linked to various cytosolic proteins.
The observation that the size of the in vivo cross-linked -Syn
species is similar to the one of in vitro cross-linked-SynDOPS
lipoprotein particles (Fig. 8; right panel, second and third lane)
indicates that the 150-kDa species corresponds to -Syn lipo-
protein particles. In agreement with this notion, it has been
demonstrated that a 150-kDa homo-multimeric -Syn species
can be present in vivo (28) suggesting that -Syn lipoprotein
FIGURE 5. The C-terminal40 residues of-Syn are flexible in-Syn lipoprotein particles as evidenced by two-dimensional [15N,1H]-TROSY spectra.
The spectra of (A) 13C, 15N-labeled-Syn free in solution and 2H, 15N-labeled (B)-SynDOPS, (C)-Syn POPS, and (D)-Syn sphingomyelin lipoprotein particles
in a buffer containing 20 mM Bis-Tris-HCl, pH 7, 20 mM NaCl were measured at a magnetic field of 700 MHz 1H frequency at 30 °C. The cross peaks are labeled
with the one-letter amino acid residue code. The slight peak doubling observed is attributed to 2H isotope effects.
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particles may indeed exist in vivo. However, it cannot be
excluded that the150-kDa band in Fig. 8 is a lipid-free -Syn
multimer as the reported toxic -Syn oligomers that accumu-
late during the process of amyloid formation (81).
Discussion
There is a significant sequence similarity between -Syn and
apolipoproteins (58). In particular, the seven imperfect repeats
in the N-terminal region of -Syn are reminiscent of those
found in the amphipathic helices of apolipoproteins (3, 6, 10,
11). Moreover, in presence of giant vesicles composed of phos-
phatidylglycerol at high protein-to-lipid ratios -Syn can form
lipoprotein nanoparticles (58) with a diameter of 7–10 nm hav-
ing a morphology and shape similar to that of the high-density
lipoproteins (HDL) and self-assembling phospholipid bilayer
nanodiscs (59) formed by human apolipoproteins and mem-
brane scaffolding proteins (MSPs), respectively.Here, we estab-
lished the preparation of stable and homogeneous samples
FIGURE6.-SynDOPS lipoproteinparticles comprise8–10copiesof-Synasevidencedbycross-linking studies. SDS-PAGE, 4–12%NuPAGEBis-Tris gel
(Invitrogen), of cross-linked -Syn DOPS lipoprotein particles. A, lane 1, molecular weightmarker (MW, Precision Plus ProteinTM Dual Color Standard, BIORAD).
Lane 2, () Non-cross-linked-SynDOPS lipoprotein particles (control). Lanes 3–8,-SynDOPS lipoprotein particles (final concentration 83M)were exposed
to increasing concentrations (molar ratios) of the amine-reactive cross-linker DSG. Arrowheads indicate presumed-Synmonomer (-S1) and oligomers (such
as -S2 for dimeric -Syn). B, lane 1, molecular weight marker (MW, SeeBlue plus2 prestained Standard, Invitrogen). Lanes 2–4, cross-linked -Syn DOPS
lipoproteinparticles (final concentration83M)with increasing concentrations ofDSGas indicated. Presumed-Synmonomer andoligomers are indicatedby
arrowheads. C, lane 1, MW, Precision Plus ProteinTM Dual Color Standard, BIORAD). Lanes 2–7, decreasing concentrations of -Syn DOPS lipoprotein particles
were exposed to a constant concentration of DSG (final concentration 249 M). Lane 8, () non cross-linked -Syn DOPS lipoprotein particles for control. D,
approximately 9gmonomeric -Syn was loaded per well. Lane 1, () non cross-linkedmonomeric -Syn control. Lanes 2–4, cross-linkedmonomeric -Syn
(final concentration 83 M) with increasing concentrations of DSG. Lane 5, MW (Precision Plus ProteinTM Dual Color Standard, Biorad).
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of nanoparticles composed of phosphatidylserine lipids and
-Syn using a protocol typically applied for the preparation of
synthetic nanodiscs (60, 61). Thismethod ensures a high extent
of sample homogeneity allowing for a detailed characterization
of the -Syn lipoprotein particles. Multiangle as well as
dynamic light scattering (MALS and DLS), electron micros-
copy (EM), cross-linking, and NMR have been used to deter-
mine the size, composition and morphology of these particles.
They are ellipsoidal discoid-like entities with a size of19–28
nm, comprising 8–10 -Syn molecules and a protein-to-lipid
ratio of 1:8 to 1:10. This data is in support with theoretical
calculations following a procedure established for MSP nano-
discs (82). Using the average surface area per one DOPS lipid
molecule of 65.3 Å2 (83), and a lipid cylinder of 20.8 nm, 9
-Syn molecules are requested for wrapping around the lipid
cylinder with helical secondary structure. The size and compo-
sition of our -Syn lipoprotein particles differ from recently
reported values of-Syn lipoprotein nanoparticles (58). Having
a similar ellipsoidal shape, the particles are approximately three
times larger (19–28 nm compared to7–10 nm) with a dou-
bled protein-to-lipid ratio (1:10 compared to 1:20). We
explain these variations by a significant different mode of
formation using either the self-assembling nanodisc approach
that starts with a detergent lipid mixture (61) or the extraction
of lipids by -Syn from phosphatidylglycerol vesicles into
nanoparticles (58).
Circular dichroism (CD) and magic angle solid-state NMR
(MAS SS-NMR) measurements confirmed the helical fold of
-Syn inside the nanoparticleswhile solution-stateNMRdeter-
mined that the 40 C-terminal residues remain flexible.
Finally, comparing in vitro with in vivo cross-linking results it
has been suggested that -Syn lipoprotein particles may occur
in vivo.
Based on the role of high-density lipoproteins (HDL) in extra
cellular cholesterol storage (84) and the high concentration of
-Syn in synapse (85), it is straight forward to propose that the
-Syn lipoprotein particle may be a storage container of nega-
tively charged lipids, that may serve as a lipid molecule source
during expansion and remodeling of the synaptic membrane
surface.While this hypothesis is sound, we failed so far to dem-
onstrate that -Syn lipoprotein particles are able to fuse with a
plasma membrane mimetic through the action of the SNARE
complex assembly together with synaptobrevin (data not
shown) (28).
In conclusion, our presented data describe a method to pre-
pare defined nanometer-sized lipid particles of -Syn and ani-
onic phospholipids. In vivo cross-linked multimeric -Syn
appeared to be similar in molecular weight as in vitro cross-
linked -Syn lipoprotein particles suggesting that they may be
of functional relevance. In our view,-Syn lipoprotein particles
may serve as a lipid molecule source during expansion and
remodeling of the synaptic membrane surface, a hypothesis
that we will further pursue.
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